Clinical heterogeneity and phenotype/genotype findings in 5 families with <i>GYG1</i> deficiency
Rabah Ben Yaou(Centre National de la Recherche Scientifique), François Petit(Hôpital Antoine-Béclère), John Vissing(University of Copenhagen), Thomas Krag(University of Copenhagen), Robert Carlier(Université de Versailles Saint-Quentin-en-Yvelines), Isabelle Nelson(University of Bonn), Maud Beuvin(Inserm), Pascal Laforêt(Assistance Publique – Hôpitaux de Paris), David Gaist(Inserm), Gisèle Bonne(Stanford University), Julia R. Dahlqvist(Inserm), Nathalie Streichenberger(Université Claude Bernard Lyon 1), Fabrice Michel(Centre Hospitalier Universitaire de Besançon), Martin Krahn(Inserm), Aurélie Hubert(Inserm), Frédéric Parisot(Inserm), Mathieu Cérino(Inserm), Morten Dunø(Copenhagen University Hospital), Norma B. Romero(Centre National de la Recherche Scientifique), B. Eymard(Assistance Publique – Hôpitaux de Paris), Philippe Labrune(Université Paris-Sud), Edoardo Malfatti(Hôpitaux Universitaires Henri-Mondor), Philippe Petiot(Inserm), Marc Bartoli(Inserm)
Cited by 16
Related Papers
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
|European Archives of Oto-Rhino-Laryngology|2020|2.8k
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
|The Lancet Neurology|2017|820
Mandibuloacral Dysplasia Is Caused by a Mutation in LMNA-Encoding Lamin A/C
|The American Journal of Human Genetics|2002|534
Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium
|Brain Pathology|2008|479
Mutations in dynamin 2 cause dominant centronuclear myopathy
|Nature Genetics|2005|462